Prelude Therapeutics Inc (PRLD)

17.65 0.00  0.00% NASDAQ Oct 26, 16:00 17.67 +0.02  +0.11% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All PRLD News

News

View All Events

Events

Date Type Description
11/10/2021 Earnings Results Q3 2021 Earnings Results
08/12/2021 Earnings Results Q2 2021 Earnings Results
06/18/2021 13:30 EST AGM 2020 Annual General Meeting
05/11/2021 Earnings Results Q1 2021 Earnings Results
03/16/2021 Earnings Results Q4 2020 Earnings Results
11/10/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
  • URL: https://www.preludetx.com
  • Investor Relations URL: https://investors.preludetx.com/
  • HQ State/Province: Delaware
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Nov. 10, 2021
  • Last Earnings Release: Aug. 12, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.